Published in PLoS One on March 25, 2015
Correction: Histone deacetylase inhibition enhances tissue plasminogen activator release capacity in atherosclerotic man. PLoS One (2015) 0.75
Dependence of Proximal GC Boxes and Binding Transcription Factors in the Regulation of Basal and Valproic Acid-Induced Expression of t-PA. Int J Vasc Med (2016) 0.75
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J (2001) 6.85
Dynamics of global histone acetylation and deacetylation in vivo: rapid restoration of normal histone acetylation status upon removal of activators and repressors. Genes Dev (2002) 2.14
Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost (2005) 1.96
Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy. J Am Coll Cardiol (2002) 1.67
Cardiac fibrinolytic capacity is markedly increased after brief periods of local myocardial ischemia, but declines following successive periods in anesthetized pigs. J Thromb Haemost (2005) 1.48
Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol (1988) 1.38
Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk. Arterioscler Thromb Vasc Biol (2006) 1.36
Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation (2001) 1.32
Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. Biochem J (1995) 1.25
Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol (2005) 1.24
Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels. Circulation (1997) 1.21
Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise. Am J Physiol Endocrinol Metab (2005) 1.18
Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses. PLoS One (2013) 1.16
Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease. Arterioscler Thromb Vasc Biol (2007) 1.14
Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension (1999) 1.07
Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cells. Cardiovasc Res (2011) 1.06
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res (2000) 1.05
Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator. Circulation (1985) 1.00
Impaired capacity for endogenous fibrinolysis in essential hypertension. Lancet (1998) 0.98
Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man. Thromb Haemost (2001) 0.97
Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J Am Coll Cardiol (1998) 0.96
Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression. PLoS One (2012) 0.96
Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitro. Thromb Res (1984) 0.91
Impaired myocardial t-PA release in patients with coronary artery disease. Acta Anaesthesiol Scand (2008) 0.90
An experimental multiple-organ model for the study of regional net release/uptake rates of tissue-type plasminogen activator in the intact pig. Thromb Haemost (1997) 0.89
Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells. J Thromb Thrombolysis (2013) 0.86
High capacity for tissue-type plasminogen activator release from vascular endothelium in vivo. J Hypertens (1997) 0.84
Valproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activity. Glia (2013) 0.82
Different cardiac tissue plasminogen activator release patterns by local stimulation of the endothelium and sympathetic nerves in pigs. Blood Coagul Fibrinolysis (2012) 0.81
Histone deacetylase inhibitor treatment increases coronary t-PA release in a porcine ischemia model. PLoS One (2014) 0.80
Profibrinolytic effect of the epigenetic modifier valproic acid in man. PLoS One (2014) 0.79
Histone deacetylase inhibitor treatment increases coronary t-PA release in a porcine ischemia model. PLoS One (2014) 0.80
Profibrinolytic effect of the epigenetic modifier valproic acid in man. PLoS One (2014) 0.79
DNA Content in Extracellular Vesicles Isolated from Porcine Coronary Venous Blood Directly after Myocardial Ischemic Preconditioning. PLoS One (2016) 0.75